
Dry eye is not always caused by insufficient tear production. For many patients, inflammation or poorly functioning meibomian glands prevents the tear film from staying stable. Envision by InMode offers two noninvasive treatments that address different contributors to dry eye - Forma-I radiofrequency and Lumecca-I intense pulsed light.
Understanding how each treatment works can help you know what to expect, but the right option depends on the findings from a professional dry eye evaluation.
Forma-I uses controlled bipolar radiofrequency energy around the eye area. The small applicator gently warms the delicate tissues surrounding the eyelids while monitoring temperature for precision and safety. Many patients describe the treatment as feeling similar to a warm massage.
The controlled warmth helps soften thickened oils inside the meibomian glands so they flow more effectively. These oils are essential for slowing tear evaporation and maintaining a stable tear film. Forma-I may be recommended for patients with evaporative dry eye related to meibomian gland dysfunction.
Lumecca-I uses intense pulsed light to deliver targeted light energy to the skin around the eyes. This creates controlled tissue heating that helps reduce inflammation and address vascular concerns. During treatment, patients see a bright flash and may feel a light snapping sensation against the skin. Temporary warmth or redness can occur and generally resolves quickly.
Lumecca-I may be considered when inflammation, ocular rosacea, or visible blood vessels around the eyelids contribute to dry eye symptoms. Research has also found that IPL can improve signs and symptoms associated with meibomian gland dysfunction.
Although both treatments are part of the Envision platform, they use different forms of energy and address dry eye in different ways:
Symptoms alone do not always reveal the source of dry eye. Burning, redness, fluctuating vision, watery eyes, and contact lens discomfort can develop from several overlapping factors. A detailed dry eye evaluation allows your eye doctor to assess your eyelids, tear film, inflammation, and meibomian glands before recommending treatment.
Forma-I may be more appropriate when blocked oil glands and rapid tear evaporation are the primary concerns. Lumecca-I may be a better fit when inflammation or vascular changes around the eyelids play a larger role. When both issues are present, combining radiofrequency and IPL may offer a more complete approach to managing meibomian gland dysfunction-related dry eye.
Both Envision treatments are performed in the office without incisions or general anesthesia. Your provider will develop a personalized treatment plan based on your symptoms, examination findings, skin characteristics, and overall eye health.
Schedule your personalized Envision dry eye evaluation with Optique Vision in Albany, New York, by calling (518) 302-2106.